NEW YORK (GenomeWeb News) – Roche’s 454 Life Sciences has inked a co-marketing deal with GenomeQuest, whereby GenomeQuest will offer its On-Demand Informatics Service to users of 454’s Genome Sequencer FLX.
According to a statement from 454, GenomeQuest’s high-throughput annotation and data-management tools enable rapid characterization of sequences generated by the GS FLX system. The co-marketing pact was signed following a pilot study to evaluate the scientific accuracy and scalability of GenomeQuest’s algorithms and informatics platform, said 454.
“When GenomeQuest first proposed to us the ability to computationally screen all of the sequences of an instrument run in one pass to provide annotated reads to our customers, we were hopeful, but cautious,” Edward Szekeres, manager of production informatics for 454, said in a statement. “Ultimately, they exceeded our expectations for each test case.”